GlassScriptPhysician profile
Deborah L Carver
NPI 1902820681
$31,758.41
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $8,967 · 2021: $9,423 · 2022: $6,743 · 2023: $3,503 · 2024: $2,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Honoraria: $1,860 · Food and Beverage: $398 · Education: $99.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Honoraria | $1,860.00 |
| Food and Beverage | $397.53 |
| Education | $99.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15,682.65 | 2021-2024 | Qulipta, Ubrelvy |
| Allergan, INC. | $12,405.03 | 2020-2021 | |
| Lundbeck LLC | $1,924.17 | 2019-2024 | Vyepti |
| Amgen INC. | $602.51 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $554.40 | 2019-2024 | Austedo Xr |
| Lilly USA, LLC | $359.40 | 2019 | |
| Eisai INC. | $121.96 | 2023 | |
| Novartis Pharmaceuticals Corporation | $108.29 | 2023 | Kesimpta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Carver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.